Targeting Nrf2/HO-1 and NF-κB/TNF-α signaling pathways with empagliflozin protects against atrial fibrillation-induced acute kidney injury in rats
Hussein Badreldin, Amr El-Karef, Tarek M. Ibrahim, Mahmoud Elshal
Topics & Concepts
EmpagliflozinAcute kidney injuryNF-κBAtrial fibrillationPharmacologyMedicineSignal transductionInternal medicineInflammationChemistryEndocrinologyDiabetes mellitusType 2 Diabetes MellitusBiochemistryDiabetes Treatment and ManagementAtrial Fibrillation Management and OutcomesAdenosine and Purinergic Signaling